Appendix 4C & Quarterly Business Update – March 2024
Genetic Technologies Ltd - American Depositary Shares (GENE)
US:NASDAQ Investor Relations:
gtgcorporate.com/investor-centre
Company Research
Source: GlobeNewswire
MELBOURNE, Australia, April 30, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly business update for the quarter ending 30 March 2024 (Q3 FY24). Key highlights: Cash Receipts totalling A$1.8m for the quarter ending March 2024.Launched targeted digital strategy for geneType CIT Sales in the United States, driving the highest level of brand engagement ever seen.Demonstrating clinician adoption – the Company has seen an increase commercial samples for the geneType portfolio of over 500%, compared to the prior corresponding 6 month period.Initiated a pilot study which includes geneType Breast Cancer Risk Assessment Test in Breast Imaging Centres across the U.S.Shareholders approved the Company to raise up to $15 million at the Extraordinary General Meeting held on 20 March 2024. Launching “K
Show less
Read more
Impact Snapshot
Event Time:
GENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GENE alerts
High impacting Genetic Technologies Ltd - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GENE
News
- GTG and ‘Wellworks for You' sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees [Yahoo! Finance]Yahoo! Finance
- GTG and 'Wellworks for You' sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees [Financial Post (Toronto, Ontario, Canada)]Financial Post
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesGlobeNewswire
- Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingGlobeNewswire
- Genetic Technologies stock tumbles on direct offering pricing [Seeking Alpha]Seeking Alpha
GENE
Sec Filings
- 5/20/24 - Form F-1
- 5/6/24 - Form 6-K
- 4/30/24 - Form 6-K
- GENE's page on the SEC website